Seubert P - Search Results

1

Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease.

Masliah E, Hansen L, Adame A, Crews L, Bard F, Lee C, Seubert P, Games D, Kirby L, Schenk D. Masliah E, et al. Among authors: seubert p. Neurology. 2005 Jan 11;64(1):129-31. doi: 10.1212/01.WNL.0000148590.39911.DF. Neurology. 2005. PMID: 15642916

2

Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies.

Lee M, Bard F, Johnson-Wood K, Lee C, Hu K, Griffith SG, Black RS, Schenk D, Seubert P. Lee M, et al. Among authors: seubert p. Ann Neurol. 2005 Sep;58(3):430-5. doi: 10.1002/ana.20592. Ann Neurol. 2005. PMID: 16130106

3

Abeta species removal after abeta42 immunization.

Nicoll JA, Barton E, Boche D, Neal JW, Ferrer I, Thompson P, Vlachouli C, Wilkinson D, Bayer A, Games D, Seubert P, Schenk D, Holmes C. Nicoll JA, et al. Among authors: seubert p. J Neuropathol Exp Neurol. 2006 Nov;65(11):1040-8. doi: 10.1097/01.jnen.0000240466.10758.ce. J Neuropathol Exp Neurol. 2006. PMID: 17086100

4

beta-peptide immunization: a possible new treatment for Alzheimer disease.

Schenk DB, Seubert P, Lieberburg I, Wallace J. Schenk DB, et al. Among authors: seubert p. Arch Neurol. 2000 Jul;57(7):934-6. doi: 10.1001/archneur.57.7.934. Arch Neurol. 2000. PMID: 10891974 Review. No abstract available.

5

Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.

Bard F, Barbour R, Cannon C, Carretto R, Fox M, Games D, Guido T, Hoenow K, Hu K, Johnson-Wood K, Khan K, Kholodenko D, Lee C, Lee M, Motter R, Nguyen M, Reed A, Schenk D, Tang P, Vasquez N, Seubert P, Yednock T. Bard F, et al. Among authors: seubert p. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2023-8. doi: 10.1073/pnas.0436286100. Epub 2003 Feb 3. Proc Natl Acad Sci U S A. 2003. PMID: 12566568 Free PMC article.

6

Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance.

Bussière T, Bard F, Barbour R, Grajeda H, Guido T, Khan K, Schenk D, Games D, Seubert P, Buttini M. Bussière T, et al. Among authors: seubert p. Am J Pathol. 2004 Sep;165(3):987-95. doi: 10.1016/s0002-9440(10)63360-3. Am J Pathol. 2004. PMID: 15331422 Free PMC article.

7

Current progress in beta-amyloid immunotherapy.

Schenk D, Hagen M, Seubert P. Schenk D, et al. Among authors: seubert p. Curr Opin Immunol. 2004 Oct;16(5):599-606. doi: 10.1016/j.coi.2004.07.012. Curr Opin Immunol. 2004. PMID: 15342006 Review.

8

Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease.

Masliah E, Rockenstein E, Adame A, Alford M, Crews L, Hashimoto M, Seubert P, Lee M, Goldstein J, Chilcote T, Games D, Schenk D. Masliah E, et al. Among authors: seubert p. Neuron. 2005 Jun 16;46(6):857-68. doi: 10.1016/j.neuron.2005.05.010. Neuron. 2005. PMID: 15953415 Free article.

9

Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease.

Buttini M, Masliah E, Barbour R, Grajeda H, Motter R, Johnson-Wood K, Khan K, Seubert P, Freedman S, Schenk D, Games D. Buttini M, et al. Among authors: seubert p. J Neurosci. 2005 Oct 5;25(40):9096-101. doi: 10.1523/JNEUROSCI.1697-05.2005. J Neurosci. 2005. PMID: 16207868 Free PMC article.

10

A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's disease.

Schenk DB, Seubert P, Grundman M, Black R. Schenk DB, et al. Among authors: seubert p. Neurodegener Dis. 2005;2(5):255-60. doi: 10.1159/000090365. Neurodegener Dis. 2005. PMID: 16909006 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters